Santen Pharmaceutical Co (JP:4536) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Santen Pharmaceutical Co., Ltd. has successfully completed the disposal of 30,715 treasury shares at a price of 1,816.0 yen per share, totaling 55,778,440 yen, as part of its Post-delivery Type Performance-Linked Stock Remuneration Plan. The shares were allocated to directors and corporate officers, excluding outside directors and three individuals who left the company. This move aligns with Santen’s long-standing commitment to eye health and its mission to deliver significant value in the prevention, diagnosis, and treatment of eye diseases.
For further insights into JP:4536 stock, check out TipRanks’ Stock Analysis page.
